Arcus Biosciences, Inc. (RCUS) Balance Sheet Annual - Discounting Cash Flows
RCUS
Arcus Biosciences, Inc.
RCUS (NYSE)
Period Ending: 2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-02-25 2024-02-21 2023-02-28 2022-02-23 2021-02-25 2020-03-05 2019-03-05 2017-12-31 2016-12-31
Total Current Assets 1,016 831 1,066 1,262 735.8 192.7 258.9 176.9 99.69
Cash and Short Term Investments 978 759 1,009 499.3 728.6 188.3 256.5 175.7 98.9
Cash & Equivalents 150 127 206 147.9 173.4 57.94 71.06 98.43 65.16
Short Term Investments 828 632 803 351.4 555.2 130.3 185.5 77.28 33.74
Receivables 25 42 43 746.8 1.7 0.132 0.083 0.025 0.405
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 13 30 14 15.62 5.47 4.3 2.32 1.14 0.39
Total Assets 1,150 1,095 1,345 1,592 772.3 203.1 274.9 190.5 109.7
Total Non-Current Assets 134 264 279 330.1 36.48 10.4 15.98 13.62 10.01
Property, Plant and Equipment 47 51 135 137.4 23.59 9.33 11.11 11.23 8.61
Goodwill and Intangible Assets 0 0 0 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0
Long Term Investments 14 107 134 185 6.64 0 4.38 0.682 1
Deferred Tax Assets 0 0 0 0 0 0 0 0 0
Other Long Term Assets 73 106 10 7.73 6.25 1.07 0.487 1.71 0.403
Total Current Liabilities 226 184 193 166.1 121.7 22.71 16.93 12.73 5.55
Accounts Payable 18 17 20 10.26 15.68 4.7 3.1 3.82 3.87
Notes Payable/Short Term Debt 12 11 3 5.1 2.87 0 0 0 0
Tax Payables 1 0 0 1.81 0 0 0 0 0
Deferred Revenue 85 91 97 102 74.57 7 6.25 5 0
Other Current Liabilities 110 65 73 46.91 28.55 11 7.58 3.91 1.68
Total Liabilities 665 633 688 750.4 270 39.27 39.98 36.62 10.24
Total Non-Current Liabilities 439 449 495 584.4 148.3 16.56 23.05 23.89 4.7
Total Long Term Debt 48 0 117 116.9 15.24 0 0 0 0
Deferred Tax Liabilities Non-Current 0 0 0 0 0 0 0 0 0
Deferred Revenue Non-Current 234 307 355 462.2 122.8 12.02 16.98 18.59 0
Capital Lease Obligations 12 11 117 116.9 15.24 0 0 0 0
Other Long Term Liabilities 145 131 -94 -111.6 -5 4.54 6.06 5.3 4.7
Total Equity 485 462 657 841.5 502.3 163.8 234.9 153.9 99.46
Non-Controlling Interest 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 485 462 657 841.5 502.3 163.8 234.9 153.9 99.46
Retained Earnings -1,132 -849 -542 -275.4 -328.2 -205.3 -122.8 -73.23 -20.15
Accumulated Other Earnings 0 0 -7 -1.26 0.044 0.064 -0.107 -0.042 -0.026
Common Stock 1,617 1,311 1,206 0.007 0.006 0.004 0.004 0.003 0.001
Preferred Stock 0 0 0 0 0 0 0 226.2 119.5
Additional Paid in Capital 0 0 0 1,118 830.4 369.1 357.9 0.948 0.183
Total Liabilities & Total Equity 1,150 1,095 1,345 1,592 772.3 203.1 274.9 190.5 109.7
Total Liabilities & Shareholders' Equity 1,150 1,095 1,345 1,592 772.3 203.1 274.9 190.5 109.7
Total Investments 842 739 937 536.4 561.9 130.3 189.9 77.96 34.74
Total Debt 60 11 120 122 18.11 0 0 0 0
Net Debt -90 -116 -86 -25.93 -155.3 -57.94 -71.06 -98.43 -65.16
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program